Latest Research | Long Covid
Latest long COVID research explores persistent symptoms, underlying mechanisms, and potential treatments. Studies reveal multi-system impacts, including cardiovascular, neurological, and respiratory issues. Researchers are investigating biomarkers for diagnosis and effective therapeutic interventions. Emerging data suggest the importance of vaccination in reducing long COVID risk. Ongoing trials aim to identify targeted therapies to alleviate prolonged symptoms and improve patient outcomes.
This is the first Paxlovid trial out looking at whether Paxlovid would work for Long COVID treatment with the thinking that if the theory of a viral reservoir, or viral persistence is causing the illness then a drug that reduces the virus should help reduce the symptoms. The results of this trial have been talked
Unite to Fight | We envision a world free of Long Covid & ME/CFS stigmatization, where every individual can thrive.
Diagnosing, measuring, and treating Long COVID is complicated, as it can present differently from person to person and persist for months or years
Functional limitations and cardiovascular symptoms in long COVID. This research focuses on investigating long COVID, particularly the cardiovascular symptoms and functional limitations associated with the condition.
ME/CFS can develop in Long Covid survivors, characterized by severe fatigue, post-exertional malaise, cognitive impairments, and sleep disturbances. Anyone, but predominantly women, can be affected. Management includes pacing, symptom-specific treatments, and multidisciplinary support.
Mast cell activation, a key component of the immune system, has been increasingly recognized as a significant contributor to the symptomatology of Long COVID. Mast cells play a crucial role in the body’s defense against pathogens and in regulating allergic responses and can manifest as persistent fatigue, brain fog, headaches, gastrointestinal issues, skin rashes, joint
A recent study published in Brain reveals that individuals suffering from long-term COVID-19 may experience significant cognitive issues for over a year. Conducted during the first wave of the pandemic, the research compared patients with ongoing symptoms to those who had fully recovered. Read More...
Battling Long Covid: The Ongoing Struggle for Those Testing Negative but Still Suffering
Cardiovascular autonomic dysfunction (CVAD) is a significant aspect of post-COVID-19 syndrome, affecting approximately one-third of highly symptomatic COVID-19 patients, and proper management is crucial for patient well-being
Viral ARDS promotes cardiac inflammation by expanding the CCR2+ macrophage subset, and the associated cardiac phenotypes in mice can be elicited by activating the host immune system even without viral presence in the heart. Read Research..